Aimei Health Technology Co., Ltd
AFJK
$12.03
-$0.25-2.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -39.91% | -63.43% | -21.50% | 40.67% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.91% | -63.43% | -21.50% | 40.67% | -- |
| Operating Income | 39.91% | 63.43% | 21.50% | -40.67% | -- |
| Income Before Tax | -77.05% | -53.54% | -58.48% | -40.65% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -77.05% | -53.54% | -58.48% | -40.65% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.05% | -53.54% | -58.48% | -40.65% | -- |
| EBIT | 39.91% | 63.43% | 21.50% | -40.67% | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -71.51% | -28.64% | -39.46% | -29.02% | -- |
| Normalized Basic EPS | -71.52% | -28.65% | -39.54% | -29.03% | -- |
| EPS Diluted | -71.51% | -28.64% | -39.46% | -29.02% | -- |
| Normalized Diluted EPS | -71.52% | -28.65% | -39.54% | -29.03% | -- |
| Average Basic Shares Outstanding | -43.94% | -40.08% | -31.57% | -11.50% | -- |
| Average Diluted Shares Outstanding | -43.94% | -40.08% | -31.57% | -11.50% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |